Právní předpis byl sestaven k datu 25.07.2019.
Zobrazené znění právního předpisu je účinné od 04.01.2018 do 25.07.2019.
80
XXXXXXX
Xxxxxxxxxxxx zahraničních xxxx,
xxxxxx xx mění x xxxxxxxx sdělení Ministerstva xxxxxxxxxxxx xxxx č. 58/2007 Xx. x. x. x x. 46/2008 Sb. x. x.
Xxxxxxxxxxxx xxxxxxxxxxxx věcí xxxxxxx, xx xxx 28. xxxxxxxxx 2016 xxxx xxxxxxxxx xxxxxxxxxx XXXXXX xxxxxxxx xxxxxxxxx xxxxxx znění Xxxxxxx X (Seznam xxxxxxxxxx xxxxx x metod xxxxxxx xxx rok 2017 - Mezinárodní xxxxxxxx) Mezinárodní úmluvy xxxxx xxxxxxx xx xxxxxx1).
X xxxxx xxxxxx Xxxxxxx X xxxxxxxx xxxxxxx Xxxxxxxxx Xxxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxx xxxxxxxx listinu x xxxxxxx změn Xxxxxxx I Xxxxxx xxxxxxxxxx.
Xxxx xxxxx Xxxxxxx X vstoupilo x xxxxxxxx x xxxxxxx x článkem 34 odst. 3 Úmluvy xxx 1. ledna 2017 x xxx Xxxxxx xxxxxxxxx vstoupilo x xxxxxxxx xxx 30. xxxxx 2017.
Xxxx xxxxxx xxxxxx xxxxx Xxxxxxx X v xxxxxxxx xxxxxxxx platit znění Xxxxxxx X xxxxxx xx 1. ledna 2016, xxxxxxxxx pod č. 26/2017 Sb. m. s.
Xxxxxxxx xxxxx Xxxxxxx X a její xxxxxxx xx xxxxxxx xxxxxx se vyhlašují xxxxxxxx.
XXXXXXX ANTIDOPINGOVÝ XXXXX
XXXXXX XXXXXXXXXX LÁTEK X XXXXX DOPINGU PRO XXX 2017
XXXXXXXXXXX STANDARD
Oficiální xxxx Xxxxxxx bude xxxxxxxxx XXXX x xxxx xxxxxxxxxx x xxxxxxxxxx x francouzštině.
V xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxxx x xxxxxxxxxxxx verzí xxxx xxxxxxxxxxx xxxxxxxx verze.
Tento Xxxxxx bude xxxxxx xx 1. xxxxx 2017
XXXXXX XXXXXXXXXX LÁTEK X METOD XXXXXXX XXX XXX 2017
SVĚTOVÝ XXXXXXXXXXXXX KODEX
Platný xx 1. xxxxx 2017
Podle xxxxxx 4.2.2 Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxx všechny Xxxxxxxx xxxxx xxxxx xxxxxxxxxx xx "Xxxxxxxxxx xxxxx" kromě xxxxx xx skupin S1, X2, X4.4, S4.5 x X6(x) x Xxxxxxxxxx xxxxx M1, X2 x M3.
|
LÁTKY X METODY XXXXXXXX XXXXX (XXX XXXXXXX X XXXX SOUTĚŽ) |
ZAKÁZANÉ XXXXX
X0. XXXXXXXXXXX LÁTKY
Jakákoliv farmakologicky xxxxxx látka, xxxxx xxxx xxxxxxxx x xxxxxxxxxxxxx xxxxxxx Seznamu x xxxx xxxxxxxx xxxxxxxxx pro humánní xxxxxxxxxxxx použití xxxxxxxxxx xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxx (např. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx stadiu xxxxxxx xxxx po ukončené xxxxxxxxxx, xxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxx xxx xxxxxxxxxxx použití), xx zakázána stále.
S1. XXXXXXXXXX XXXXX
Xxxxxxxxxx xxxxx xxxx xxxxxxxx.
1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):
(x) Xxxxxxxx* XXX, xxxxxxxxxx:
1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx);
1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion);
bolandiol (xxxx-4-xx-3ß, 17ß-xxxx);
xxxxxxxxxx;
xxxxxxx ([1,2]xxxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx);
xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);
xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17ß-xx);
xxxxxxxxxxx;
xxxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx);
xxxxxxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxx (17α-methyl[1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17ß-ol);
gestrinon;
4-hydroxytestosteron (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx);
xxxxxxxxxx;
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);
xxxxxxxxx;
xxxxxxxxxxx;
xxxxxxxxxx (17ß-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx);
xxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx);
xxxxxx-1-xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxx-5α-xxxxxxx-1-xx-3-xx);
xxxxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx);
xxxxxXxxxxxxxxxxx;
xxxxxxxxxx (xxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxxxxx;
xxxxxxxxxxxx;
xxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx);
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxx;
1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx);
xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx);
xxxxxxxxx (17ß-hydroxyestr-4,9,11-trien-3-on);
a xxxxx xxxxx s xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.
x. Xxxxxxxxx** XXX, xxxxx xxxx podány xxxxxxxx:
Xxxxxxxxxxxxx (xxxxxxx-5-xx-3ß,17ß-xxxx);
xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx);
xxxxxxxx;
xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx);
xxxxxxxxxxxxxxxxxx (17ß-hydroxy-5α-androstan-3on);
nandrolon (19-xxxxxxxxxxxxxx);
19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);
19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);
xxxxxxxxx (dehydroepiandrosteron, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx);
xxxxxxxxxxx;
x xxxxxx xxxxxxxxxx x xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
5α-xxxxxxxxx-3α,17α-xxxx;
5α-xxxxxxxxx-3α,17ß-xxxx;
5α-xxxxxxxxx-3ß,17α-xxxx;
5α-xxxxxxxxx-3ß,17ß-xxxx;
5ß-xxxxxxxxx-3α,17ß-xxxx;
5α-xxxxxxx-2-xx-17-xx;
xxxxxxx-4-xx-3α,17α-xxxx;
xxxxxxx-4-xx-3α,17ß-xxxx;
xxxxxxx-4-xx-3ß,17α-xxxx;
xxxxxxx-5-xx-3α,17α-xxxx;
xxxxxxx-5-xx-3α,17ß-xxxx;
xxxxxxx-5-xx-3ß,17α-xxxx;
4-xxxxxxxxxxxxx (androst-4-en-3ß,17ß-diol);
5-androstendion (androst-5-en-3,17-dion);
androsteron;
epi-dihydrotestosteron;
epitestosteron;
etiocholanolon;
3ß-hydroxy-5α-androstan-17-on;
7α-hydroxy-DHEA;
7ß-hydroxy-DHEA;
7-keto-DHEA;
19-norandrosteron;
19-noretiocholanolon.
2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:
Xxxxxxxxxxx; xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX, xxxx. andarin x xxxxxxx); xxxxxxx; xxxxxxx x zilpaterol, xxx xx s xxxxxxxx xxxxx xx ně.
|
Pro xxxxx xxxxxxx xxxx xxxxx: * "exogenní" xx xxxxxxxx x xxxxx, xxxxxx tělo xxxxxxxx xxxxxxxxx xxxxxxxxxxx. ** "endogenní " se vztahuje x xxxxx, xxxxxx xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx. |
X2. PEPTIDOVÉ XXXXXXX, XXXXXXX XXXXXXX, XXXXXXXX XXXXX A MIMETIKA
Následující xxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx strukturou xxxx xxxxxxxxx biologickými xxxxxx xxxx xxxxxxxx:
1. Agonisté xxxxxxxxxxxxxxxxx xxxxxxxxx:
1.1 Látky xxxxxxxxxxx erytropoesu (XXX) xxxxxx xxxx.
xxxxxxxxxxxx (xXXX);
xxxxxxxxxxxxx (XXX);
XXX-Xx;
XXX-xxxxxxxxxxx peptidů (XXX), xxxx. CNTO 530 x xxxxxxxxxxx;
xxxxxxxxxx XXXX, xxxx. K-11706;
methoxypolyethylenglykol-epoetin xxxx (XXXX);
xxxxxxxxxx transformujícího xxxxxxxxx xxxxxxx xxxx (XXX-xxxx), xxxx. sotatercept, luspatercept;
1.2 Xxxxxxxx xxxxxxxxxxxxxxxxxx XXX xxxxxxxxx, např.
ARA-290;
asialo XXX;
xxxxxxxxxxxxx XXX;
2. Xxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx (XXX), xxxx. xxxxxx, xxxxxxxxxx x xxxxxxxxxx (XX-4592); x xxxxxxxxxx HIF, xxxx. xxxxx a xxxxx.
3. Xxxxxxxxxxxxxxxxxx (CG) x xxxxxxxxxxxx xxxxxx (XX) x jejich xxxxxxxxxx faktory, xxxx. xxxxxxxxx, xxxxxxxxxxx a xxxxxxxxxxx, x xxxx.
4. Xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxx xxxxxxx, např. xxxxxxxxxxxx.
5. Xxxxxxx xxxxxx (XX) x xxxx xxxxxxxxxx faktory xxxxxx: xxxxxxx uvolňujícího xxxxxxx xxxxxx (GHRH) a xxxx xxxxxxx, xxxx. XXX-1295, xxxxxxxxxxx a xxxxxxxxxxxx; xxxxxxxxxxx xxxxxxxxx xxxxxxx (XXX), xxxx. xxxxxxxx a xxxxxxx xxxxxxxx, xxxx. xxxxxxxxxxx x ipamorelinu; uvolňujících xxxxxxx xxxxxxxxx xxxxxxx (XXXX), xxxx. xxxxxxxxxxxxx, XXXX-6, xxxxxxxxxx x xxxxxxxxxxxx (XXXX- 2).
Xxxxx xxxx jsou zakázány xxxxxxxxxxx xxxxxxx faktory:
Fibroblastové xxxxxxx xxxxxxx (XXXx); xxxxxxxxxxxx xxxxxxx xxxxxx (XXX); xxxxxxxx podobný xxxxxxx xxxxxx-1 (XXX-1) x xxxx xxxxxxx; xxxxxxxxxx xxxxxxx faktory (XXX); xxxxxxx faktor xxxxxxxx x xxxxxxxx xxxxxxxx (XXXX); xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx xxxxxx (XXXX), xxxxxx xxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx xxxxxxxxxxx syntézu xxxx xxxxxxxxx bílkovin svalů, xxxxx x vaziva, xxxxxx zásobení, xxxxxxx xxxxxxx, regenerativní xxxxxxxx xxxx ovlivňující xxxx xxxxxxxxx xxxxxx.
X3. XXXX2- XXXXXXXX
Xxxxxxx selektivní i xxxxxxxxxxxx xxxx2- agonisté, xxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxx xxxxxxxx.
Xxxxxxxx (xxx xx x xxxxxxxx pouze xx xx):
Xxxxxxxxx; formoterol; xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; salbutamol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx.
Xxxxxxxx jsou:
- inhalační xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx, xxxxxxxxxxx 800 xxxxxxxxxx za každých 12 xxxxx;
- xxxxxxxxx xxxxxxxxxx: xxxxxxxxx xxxxxx dávka 54 xxxxxxxxxx za 24 xxxxx;
- xxxxxxxxx salmeterol: xxxxxxxxx 200 mikrogramů xx 24 xxxxx.
Xxxxxxxxxx xxxxxxxxxxx x xxxx x xxxxxxxxxxx xxxxx xxx 1000 ng/ml x xxxxxxxxxx formoterolu x xxxx x xxxxxxxxxxx xxxxx xxx 40 xx/xx xxxxxx xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxx, xxx xxxx považována xx xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx sportovec xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxx, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxx (v xxxxxxxx) nižší, xxx xxxx uvedená maximální xxxxx.
X4. XXXXXXXXX A XXXXXXXXXXX MODULÁTORY
Zakázané jsou xxxxxxxxxxx hormonové x xxxxxxxxxxx xxxxxxxxxx:
1. Inhibitory xxxxxxxx, xxxxxxxxxx:
Xxxxxxxxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxx-1,4,6-xxxxx-3-17-xxxx (xxxxxxxxxxxxxxxxx);
xxxxxxxx-3,5-xxxx-7-17-xxxx (xxxxxxxxx);
4-xxxxxxxxx-3,6,17-xxxxx (6-oxo);
exemestan;
formestan;
letrozol;
testolacton,
ale xx x xxxxxxxx pouze xx ně.
2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (XXXX), xxxxxxxxxx:
Xxxxxxxxx;
tamoxifen;
toremifen, xxx xx s xxxxxxxx pouze na xx.
3. Ostatní xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:
Xxxxxxxxxx; fulvestrant x klomifen, ale xx s omezením xxxxx xx ně.
4. Xxxxx xxxxxxxxxxxx funkci(e) xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx
x xxxxxxxx xxxxx xx xx.
5. Metaboiické xxxxxxxxxx:
5.1 Xxxxxxxxxx AMP-aktivované xxxxxxxxxxxxx (XXXX), xxxx. XXXXX; x Agonisté Xxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx (PPARδ), xxxx. XX 1516;
5.2 Xxxxxxxx x xxxxxxxx insulinů;
5.3 Xxxxxxxxx;
5.4 Trimetazidin.
S5. XXXXXXXXX X XXXXXXXXX XXXXX
Xxxxxxxxxxx xxxxxxxxx a maskovací xxxxx jsou zakázané, xxxxxx xxxx xxxxx xxxxx x podobnou xxxxxxxxx strukturou x xxxxxxxxx biologickými xxxxxx.
Xxxxxxxx:
-
Xxxxxxxxxxxx, xxxxxxxxxxxxxxx (např. xxxxxxxx, xxxxxxxxxx podání albuminu, xxxxxxxx, xxxxxxxxxxxxxxxxxx a xxxxxxxxx), probenecid, xxx xx x omezením xxxxx na xx.
-
Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x vaptany (xxxx. xxxxxxxxx), xxx xx x xxxxxxxx xxxxx xx xx.
X xxxxxxxx:
-
xxxxxxxxxxxx, xxxxxxxxx a xxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxxxxx (xxxx. xxxxxxxxxxx x xxxxxxxxxxxx)
-
Xxxxxxxxx podání xxxxxxxxxxxx pro xxxxx xxxxxxxxx
Xxxxx jakéhokoliv xxxxxxxx xxxxx xx stanoveným xxxxxxxx xxxxxxx (xx. xxxxxxxxxx, xxxxxxxxxx, xxxxx, xxxxxxx, xxxxxxxxxxxx x xxxxxxxxxxxxx) ve Vzorku Xxxxxxxxx kdykoliv xxxx
xxxxxxxx Xxx Soutěži ve xxxxxxx x xxxxxxxxxx xxxx jinou xxxxxxxxx xxxxxx, bude xxxxxxxxxx xx Pozitivní laboratorní xxxxx, pokud Sportovec xxxx xxxxxxxxxx Xxxxxxxxxxxxx xxxxxxx (XX) xx xxxx xxxxx xxxxx x té, která xxx xxxx udělena xx xxxxxxxxxx nebo xxxxx xxxxxxxxx xxxxx.
XXXXXXXX XXXXXX
X1. XXXXXXXXXX X XXXX A XXXXXXXX XXXXXXXXXXXX
Xxxxxxxx je xxxxxxxxxxx:
1. Xxxxxx nebo xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx, xxxxxxxx (xxxxxxxxx) nebo xxxxxxxxxxx krve xxxx xxxxxxxxx krvinek x xxx podobných produktů xxxxxxxxxxx xxxxxx do xxxxxxxxx systému.
2. Xxxxx xxxxxxxxx spotřeby, xxxxxxx xxxx xxxxxxx xxxxxxx.
Xxxxxxxxxx:
xxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxx (např. xxxxxx náhražky xxxxxxxx xx hemoglobinu a xxxxxxxxxxxxxxxxxx xxxxxxxxxxx), perfluorochemikálie x xxxxxxxxxxx (RSR13), xxx ne s xxxxxxxx xxxxx na xx. Xxxxxxxxx suplementace xxxxxxxx zakázána xxxx.
3. Xxxxxxxxx xxxxx intravaskulární xxxxxxxxxx x xxxx xxxx x xxxxxxxx xxxxxxxxxxxx fyzikálními xxxx xxxxxxxxxx xxxxxxx.
X2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
1. Xxxxxxxxx, xxxx Xxxxx x Xxxxxx, za účelem xxxxxxx xxxxxxxxx a xxxxxxxx Vzorků xxxxxxxxxx xxx Xxxxxxxxx kontrole. Xx xxxxxxxx xxxxxx x/xxxx xxxxxx (xxxx. xxxxxxxxxx) moči, xxx xx x xxxxxxxx xxxxx na ně.
2. Xxxxxxxxxx xxxxxx x/xxxx xxxxxxx xxxx xxx 50 xx xx 6 hodin xxxxx xxxxxx xxxxxxxxx přijatých x průběhu xxxxxxxxxxxx xxxxxxx, chirurgických xxxxxxx xxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxx.
X3. XXXXXX DOPING
Z xxxxxx potenciálu xx xxxxxxx sportovního xxxxxx xx xxxxxxxx xxxxxxxxxxx:
1. Xxxxxxxx xxxxxxxx nukleových xxxxxxx xxxx jejich xxxxxxx;
2. Xxxxxxx normálních xxxx xxxxxxxxx modifikovaných xxxxx;
|
XXXXX X XXXXXX XXXXXXXX XXX XXXXXXX |
Xxxxx xxxxxxxxx X0 xx X5 a M1 xx X3 uvedených xxxx
xxxx Při Xxxxxxx xxxxxxxx x následující xxxxxxx:
XXXXXXXX XXXXX
X6. STIMULANCIA
Všechna xxxxxxxxxxx včetně xxxxx xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx, xxxx. d- x X-, jsou xxxxxxxx.
Xxxxxxxxxxx zahrnují:
(a) Nespecifická xxxxxxxxxxx:
Xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxx /4-xxxxxxxxxxxxxx (karfedon)/,
furfenorex,
klobenzorex,
kokain,
kropropamid,
krotetamid,
lisdexamfetamin,
mefenorex,
mefentermin,
metamfetamin (x-),
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxxxx,
x-xxxxxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx.
Xxxxxxxxxxxx, které není xxxxxxxx uvedeno v xxxxx xxxxxxxx, xx Xxxxxxxxxxx látkou.
(b) Xxxxxxxxxx xxxxxxxxxxx.
Xxxxxxxx (xxx xx x xxxxxxxx pouze xx xx):
Xxxxxxxxx (epinefrin)****,
benzfetamin,
dimethylamfetamin,
efedrin***,
etamivan,
etylamfetamin,
etylefrin,
famprofazon,
fenbutrazát,
fenetylamin x jeho xxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxx),
xxxxxxxxxxxx,
xxxxx**,
xxxxxxx x xxxx xxxxxxx (např. xxxxxxxx, xxxxxxxxx x xxxx-xxxxxxxxxxxxxxxxxxxxx),
xxxxxxxxxxxxxxx,
xxxxxxxxxxxx,
xxxxxxxxxxxx***,
xxxxxxxxxxxxxxxxxxxxxxxx,
xxxxxxxxxxxx,
4-xxxxxxxxxx-2-xxxx (xxxxxxxxxxxxxx),
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxx (xxxxxxxxxxxxx),
xxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxxxxx,
xxxxxxxxxxxxx*****,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxx (metylendioxyamfetamin),
tuaminoheptan
a xxxxx xxxxx x xxxxxxxx chemickou strukturou xxxx xxxxxxxxx biologickými xxxxxx.
X xxxxxxxx:
-
xxxxxxxxx
-
xxxxxxxx xxxxxxxxx x xxxxxxx jejich xxxxxxxx/xxxxxx xxxxxxx a xxxxxxxxxxx xxxxxxxxxx do Xxxxxxxxxxxxxx programu xxx xxx 2017*.
* Bupropion, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxx, xxxxxxx, xxxxxxxxx x xxxxxxxx: Tyto xxxxx xxxx xxxxxxxx do Xxxxxxxxxxxxxx programu 2017 x nejsou považovány xx Xxxxxxxx xxxxx.
** Xxxxx: xx xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx než 5 xxxxxxxxxx x 1 xx xxxx.
*** Xxxxxxx x methylefedrin: jsou xxxxxxxx xxx xxxxxxxxxxx xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.
**** Xxxxxxxxx (xxxxxxxxx): xxxx xxxxxxx xxx xxxxxxxx podání, xxxx. nosní, oční xxxxxxxx xxxx jeho xxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxx.
***** Xxxxxxxxxxxxx: xx zakázán, xxxxx xxxx xxxxxxxxxxx v xxxx xx vyšší xxx 150 xxxxxxxxxx xx xxxxxxxx.
X7. XXXXXXXXX
Xxxxxxxx xx následující:
Buprenorfin,
dextromoramid,
diamorfin(heroin),
fentanyl a xxxx xxxxxxxx,
xxxxxxxxxxx,
xxxxxxx,
xxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxx.
X8. XXXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
-
Xxxxxxxx (xxxx. xxxxx, konopí x xxxxxxxxx) xxxx xxxxxxxxxx xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX).
-
Xxxxxxxxxxxxxx, xxxx. "Xxxxx", XXX018, JWH073 x XX-210.
X9. GLUKOKORTIKOIDY
Všechny xxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, nitrožilní nebo xxxxxxxxxxxxx xxxxxxxx jsou xxxxxxxx.
|
XXXXX XXXXXXXX X&xxxx;XXXXXXXX XXXXXXXX |
X1. ALKOHOL
Alkohol (xxxxxx) xx zakázaný pouze Xxx Soutěži x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx bude xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Prahová xxxxxxx pro xxxxxxxx xxxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxx koncentraci alkoholu x xxxx 0,10 x/x.
-
Xxxxxxxxxxxx xxxxx (XXX)
-
Xxxxxxxxxxx (XX)
-
Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)
-
Xxxxx xxxxxxxxxx (XXX)
X2. XXXX-XXXXXXXXX
Xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx x xxxxxxxxxxxxx xxxxxxxx Xxx Xxxxxxx, a xxx xx xx xxxxxxxx x Xxxx xxxxxx.
-
Xxxxxxxxxxxx xxxxx (FIA)
-
Billiard (všechny xxxxxxxxxx) (XXXX)
-
Xxxx (IGF)
-
Lukostřelba (XX)*
-
Xxxxxxxx (XXX) - xxxxx xx xxxxxx x xxxxxxxxxxx lyžování-skoky x U-rampa, x xxxxxxxxx X-xxxxx x "xxx xxx"
-
Xxxxxxxx xxxxxx (xxxxxxxxx potápění) (CMAS) x xxxxxxxxxxxx konstantní xxxx x ploutvemi xxxx bez ploutví, xxxxxxxxx apnoe x xxxxxxxxx nebo xxx xxxxxxx, xxxx xxxxxxxxx, xxxx xxxx, xxxxxxxxxxxx, xxxxxxxx apnoe, xxxxxxx xxxxxxxx na xxxx x xxxxxxxxxx xxxx.
-
Xxxxxxx (XXXX, IPC)*
-
Šipky (WDF)
* Xxxxxxxx xxxx Mimo xxxxxx
Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:
Xxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxxxx,
xxxxxxx,
xxxxxxx,
xxx ne x xxxxxxxx xxxxx xx xx.
Xxxxxxxxx
Xxxxxx předpis x. 80/2017 Xx. x. x. xxxxx xxxxxxxxx xxxx 4.1.2018.
Xxxxxx předpis x. 80/2017 Xx. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 36/2019 Sb. m. s. s účinností xx 26.7.2019.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx uvedeného právního xxxxxxxx.
1) Mezinárodní úmluva xxxxx xxxxxxx ve xxxxxx, xxxxxxx xxx 19. října 2005 x Paříži, xxxx xxxxxxxxx x xxxxxxxxx xxxxx x x xxxxxxxxx xx xxxxxxx xxxxxx pod č. 58/2007 Sb. m. s.
Xxxx xxxxx překladu Xxxxxx xx xxxxxxx xxxxxx xxxx xxxxxxxxx pod č. 46/2008 Sb. m. s.